|
|
The Board of Directors of SciBase resolves on a previously communicated rights issue of shares of approximately SEK 83 million |
|
|
SciBase Expands Its Intellectual Property Portfolio to include the analysis of the epithelial skin barrier with New European Patent |
|
|
SciBase publishes information document regarding the offer to repurchase outstanding warrants of series TO 2 |
|
|
Bulletin from the extraordinary general meeting in SciBase Holding AB (publ) |
|
|
The exercise price for warrants of series TO 3 has been determined |
|
|
Notice to attend the extraordinary general meeting in Scibase Holding AB (publ) |
|
|
Interim report |
|
|
The Board of Directors in SciBase resolves on an offer to repurchase outstanding warrants of series TO 2 and intends to resolve on a rights issue of shares of approximately SEK 83 million |
|
|
SciBase and Castle Biosciences expand collaboration and license agreement and enter into loan agreement of SEK 20 million |
|
|
Nomination Committee appointed for SciBase Holding's Annual General Meeting in 2026 |
